Summit Therapeutics
SMMT
SMMT
58 hedge funds and large institutions have $30.4M invested in Summit Therapeutics in 2021 Q2 according to their latest regulatory filings, with 25 funds opening new positions, 19 increasing their positions, 10 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
0.15% more ownership
Funds ownership: 11.21% → 11.37% (+0.15%)
44% less capital invested
Capital invested by funds: $54.6M → $30.4M (-$24.2M)
Holders
58
Holding in Top 10
–
Calls
$1.05M
Puts
$235K
Top Buyers
| 1 | +$2.6M | |
| 2 | +$2.46M | |
| 3 | +$1.92M | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$1.32M |
| 5 |
Fidelity International
Hamilton,
Bermuda
|
+$777K |
Top Sellers
| 1 | -$2.03M | |
| 2 | -$785K | |
| 3 | -$549K | |
| 4 |
Goldman Sachs
New York
|
-$342K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$251K |